Reanalysis for PK Reason: Gone with the Wind [Bioanalytics]

posted by Ohlbe – France, 2020-07-16 19:15 (271 d 21:41 ago) – Posting: # 21721
Views: 2,956

Dear Helmut,

» » » According to the current guidelines (EMA 2011, FDA 2018, ICH draft 2019) it is no more acceptable. IMHO, bad science.
» »
» » Agreed.
»
» Agreed on what? That is not acceptable or that it is bad science?

That it is bad science, of course ! To accept as a matter of principle data which are obviously incorrect, and to refuse as a matter of principle for these data to be corrected, is something I fail to understand.

I understand that assessors may be suspicious if there were some re-analyses for PK reasons. If the study is only borderline passing, they always have the possibility to perform (or ask for) a statistical analysis with the original data. Depending on the outcome, they may ask for an inspection.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,417 posts in 4,475 threads, 1,508 registered users;
online 10 (0 registered, 10 guests [including 2 identified bots]).
Forum time: Wednesday 16:56 CEST (Europe/Vienna)

Old beliefs die hard
even when demonstrably false.    E. O. Wilson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5